PERSPECTA

News from every angle

← Back to headlines

AbbVie's AQUIPTA® Approved by European Commission

AbbVie (ABBV) has announced that the European Commission has approved its drug AQUIPTA®.

5 Jun, 22:04 — 5 Jun, 22:04
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual88d ago

AbbVie (ABBV) Announces European Commission’s Approval of AQUIPTA®

Read full article →

Related Stories

Oil and Gas Prices Surge Following Renewed U.S. Strikes on Iran

55m ago

South Korea Inflation Rises to 3.1 Percent in August

1h ago

Dell Raises Full-Year Forecast After Strong AI-Driven Earnings

1h ago

EU Tourism Data Shows Divergent Trends as Cyprus Suffers Steepest Decline

1h ago